Extended spectrum of quinolone resistance, even to a potential latter third-generation agent, as a result of a minimum of two GrlA and two GyrA alterations in quinolone-resistant staphylococcus aureus

Chemotherapy

Volumn 56, Issue 2, 2010, Pages 153-157

  Yoon, Eun Jeong ^a   Lee, Chun Yeong ^b   Shim, Mi Ja ^b   Min, Yu Hong ^c   Kwon, Ae Ran ^c   Lee, Jongseo ^a   Choi, Eung Chil ^a  

^a Seoul National University   (South Korea)

^b University of Seoul   (South Korea)

^c Daegu Haany University   (South Korea)

Author keywords

DNA gyrase; Quinolone resistant Staphylococcus aureus; Topoisomerase IV

Indexed keywords

CIPROFLOXACIN; DNA FRAGMENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE IV; DW 286; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SPARFLOXACIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS;

EID: 77950956868     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313529     Document Type: Article

References (14)

1. Andersson MI, MacGowan AP: Development of the quinolones. J Antimicrob Chemother 2003; 51(suppl 1):1-11.
2. Lee CC, Lee VW, Chan FK, Ling TK: Levofloxacin-resistant Helicobacter pylori in Hong Kong. Chemotherapy 2008; 54: 50-53.
3. Entenza JM, Que YA, Vouillamoz J, Glauser MP, Moreillon P: Efficacies of moxifloxacin, ciprofloxacin and vancomycin against experimental endocarditis due to methicillinresistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob Agents Chemother 2001; 45: 3076-3083.
4. Kim MJ, Yun HJ, Kang JW, Kim S, Kwak JH, Choi EC: In vitro development of resistance to a novel quinolone, DW286, in methicillinresistant Staphylococcus aureus clinical isolates. J Antimicrob Chemother 2003; 51: 1011-1016.
5. Ball P: Quinolone generations: natural history or natural selection? J Antimicrob Chemother 2000; 46(suppl T1):17-24.
6. Yun HJ, Min YM, Jo YW, Shim MJ, Choi EC: Increased antimicrobial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV. Int J Antimicrob Agents 2005; 25: 334-337.
7. Yun HJ, Min YH, Lim JA, Kang JW, Kim SY, Kim MJ, Jeong JH, Choi YJ, Kwon HJ, Jung YH, Shim MJ, Choi EC: In vitro and in vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic. Antimicrob Agents Chemother 2002; 46: 3071-3074.
8. Tanaka M, Wang T, Onodera Y, Uchida Y, Sato K: Mechanism of quinolone resistance in Staphylococcus aureus . J Infect Chemother 2000; 6: 131-139.
9. Horii T, Suzuki Y, Takeshita A, Maekawa M: Molecular characterization of 8-methoxyfluoroquinolone resistance in a clinical isolate of methicillin-resistant Staphylococcus aureus . Chemotherapy 2007; 53: 104-109.
10. Schmitz FJ, Fluit AC, Luckefahr M, Engler B, Hofmann B, Verhoef J, Heinz HP, Hadding U, Jones ME: The effect of reserpine, an inhibitor of multidrug efflux pumps, on the invitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus . J Antimicrob Chemother 1998; 42: 807-810.
11. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard, ed 5 M7-A5. Wayne, National Committee for Clinical Laboratory Standards, 2000.
12. Yamagishi JI, Kojima T, Oyamada Y, Fujimoto K, Hattori H, Nakamura S, Inoue M: Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus . Antimicrob Agents Chemother 1996; 40: 1157-1163.
13. Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S: Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus . Antimicrob Agents Chemother 1994; 38: 2014-2023.
14. Schmitz FJ, Jones ME, Hofmann B, Hansen B, Scheuring S, Luckefahr M, Fluit A, Verihoef J, Hadding U, Heinz HP, Kohrer K: Characterization of grlA , grlB , gyrA and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob Agents Chemother 1998; 42: 1249-1252.